2025 US Public Health Service Guidelines for the Management of Occupational Exposures to Human Immunodeficiency Virus and Recommendations for Post-exposure Prophylaxis in Healthcare Settings
Infection Control & Hospital Epidemiology · 2025-09 · 46 (9) · 863-873
DOI: 10.1017/ice.2025.10254 ↗Kurz gefasst
Leitlinie in der Zeitschrift Infection Control & Hospital Epidemiology, online erschienen am 15.09.2025. Verfasst von Aaron D Kofman und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Disease, Centers for Disease Control and Prevention, A…. Hauptthemen laut MEDLINE: HIV Infections, Post-Exposure Prophylaxis, Occupational Exposure, Infectious Disease Transmission, Patient-to-Professional. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
These guidelines update the 2013 “Updated US Public Health Service (PHS) Guidelines for the Management of Occupational Exposures to Human Immunodeficiency Virus and Recommendations for Postexposure Prophylaxis,” hereafter referred to as the 2013 PHS Guidelines. 1,2 The availability of new medication options, new information on the window of detection for different human immunodeficiency virus (HIV) tests, and the risk of transmission from people with undetectable viral loads prompted this update. The primary intended audience for these recommendations remains anyone involved in the provision of HIV post-exposure management to healthcare personnel (HCP). The U.S. Centers for Disease Control and Prevention assembled a working group of representatives from federal agencies in the U.S. Department of Health and Human Services (HHS) who identified the priority topics for update and conducted systematic literature reviews to formulate recommendations (see Appendix). All recommendations were reviewed by the Healthcare Infection Control Practices Advisory Committee (HICPAC) at public meetings, and by a non-consensus forming panel of external experts. New evidence-based recommendations are developed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework and classified according to the HICPAC recommendation scheme when evidence supported recommendation development. 3,4 Other recommendations in this document are classified as good practice statements according to the criteria set forth by GRADE. 5 The working group solicited additional feedback on recommendations from relevant agencies, subject-matter experts, and the public. Recommendations that have changed since the 2013 PHS guidelines include: new antiretroviral drug regimens for post-exposure prophylaxis (PEP); a shortened duration of post-exposure follow-up HIV testing; elimination of routine laboratory tests for antiretroviral drug toxicity; and considerations for PEP for HCP with exposures to source patients with undetectable viral loads. Important strategies in the principles of exposure management remain: primary prevention strategies; the prompt reporting and management of occupational exposures; adherence to recommended HIV PEP regimens when indicated; the role of expert consultation in management of exposures; and follow-up of exposed HCP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Disease, Centers for Disease Control and Prevention, Atlanta, GA, USA.
- Division of Antiviral Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
- Division of HIV Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
- HIV/AIDS Bureau, The Health Resources and Services Administration, Rockville, MD, USA.
- Office of the Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Cincinnati, OH, USA.
- Chenega Enterprise Systems and Solutions, Chesapeake, VA, USA.
ORCID-Profile: Aaron D Kofman, Kimberly A Struble, Walid Heneine, Britt Gayle, Marie A de Perio, Devon L Okasako-Schmucker, Christine N So, Laura E Anderson, Erin C Stone, David K Henderson, David T Kuhar
Zitieren
APA
Kofman, A. D., Struble, K. A., Heneine, W., Gayle, B., de Perio, M. A., Okasako-Schmucker, D. L., So, C. N., Anderson, L. E., Stone, E. C., Henderson, D. K., & Kuhar, D. T. (2025). 2025 US Public Health Service Guidelines for the Management of Occupational Exposures to Human Immunodeficiency Virus and Recommendations for Post-exposure Prophylaxis in Healthcare Settings. Infection Control & Hospital Epidemiology, 46(9), 863-873. https://doi.org/10.1017/ice.2025.10254
Vancouver
Kofman AD, Struble KA, Heneine W, Gayle B, de Perio MA, Okasako-Schmucker DL, et al. 2025 US Public Health Service Guidelines for the Management of Occupational Exposures to Human Immunodeficiency Virus and Recommendations for Post-exposure Prophylaxis in Healthcare Settings. Infection Control & Hospital Epidemiology. 2025;46(9):863-873. doi:10.1017/ice.2025.10254
BibTeX
@article{Kofman2025,
author = {Kofman, Aaron D and Struble, Kimberly A and Heneine, Walid and Gayle, Britt and de Perio, Marie A and Okasako-Schmucker, Devon L and So, Christine N and Anderson, Laura E and Stone, Erin C and Henderson, David K and Kuhar, David T},
title = {2025 US Public Health Service Guidelines for the Management of Occupational Exposures to Human Immunodeficiency Virus and Recommendations for Post-exposure Prophylaxis in Healthcare Settings},
journal = {Infection Control & Hospital Epidemiology},
year = {2025},
volume = {46},
number = {9},
pages = {863--873},
doi = {10.1017/ice.2025.10254}
}
EUVIMED